# The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction

> **NCT00895570** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 20 (actual)

## Conditions studied

- Sleep Restriction
- Impaired Glucose Metabolism

## Interventions

- **DRUG:** modafinil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00895570
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895570, "The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00895570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*